Detalhe da pesquisa
1.
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Lancet Oncol
; 25(3): 317-325, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38342115
2.
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
Oncologist
; 25(8): e1233-e1241, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32476162
3.
Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Transplant Cell Ther
; 29(7): 440-448, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37031747
4.
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar.
Immunotherapy
; 14(9): 727-740, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35543293
5.
Impact of early detection on cancer curability: A modified Delphi panel study.
PLoS One
; 17(12): e0279227, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36542647
6.
Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura.
Am J Hematol
; 90(3): 264-6, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25196665
7.
A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study.
Cancer Med
; 9(17): 6234-6243, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32687266
8.
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
Target Oncol
; 15(6): 807, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33180232
9.
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product.
Target Oncol
; 15(5): 599-611, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33044684
10.
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer.
Support Care Cancer
; 17(8): 1081-8, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19148686
11.
Symptom trajectories in posttreatment cancer survivors.
Cancer Nurs
; 34(1): 67-77, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-20885306
12.
Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma.
Eur J Oncol Nurs
; 15(5): 470-7, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21251874
13.
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
Breast
; 18(2): 78-83, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19342237
14.
Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.
Invest New Drugs
; 24(6): 537-42, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-16832602